Deutsche Bank AG Takes $2.19 Million Position in Pediatrix Medical Group, Inc. $MD

Deutsche Bank AG bought a new position in Pediatrix Medical Group, Inc. (NYSE:MD) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 86,424 shares of the company’s stock, valued at approximately $2,189,000.

A number of other hedge funds have also made changes to their positions in MD. Keybank National Association OH lifted its holdings in Pediatrix Medical Group by 2.0% during the 1st quarter. Keybank National Association OH now owns 22,941 shares of the company’s stock valued at $491,000 after purchasing an additional 458 shares during the last quarter. Gotham Asset Management LLC grew its stake in Pediatrix Medical Group by 0.6% during the third quarter. Gotham Asset Management LLC now owns 116,093 shares of the company’s stock worth $1,945,000 after buying an additional 724 shares during the last quarter. ProShare Advisors LLC grew its stake in Pediatrix Medical Group by 4.6% during the fourth quarter. ProShare Advisors LLC now owns 16,816 shares of the company’s stock worth $360,000 after buying an additional 734 shares during the last quarter. Verition Fund Management LLC increased its holdings in shares of Pediatrix Medical Group by 4.4% during the third quarter. Verition Fund Management LLC now owns 25,408 shares of the company’s stock worth $426,000 after buying an additional 1,066 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its stake in shares of Pediatrix Medical Group by 77.7% in the first quarter. EverSource Wealth Advisors LLC now owns 2,515 shares of the company’s stock valued at $54,000 after acquiring an additional 1,100 shares during the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Weiss Ratings downgraded Pediatrix Medical Group from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday. Jefferies Financial Group downgraded Pediatrix Medical Group from a “buy” rating to a “hold” rating and lifted their price objective for the company from $27.00 to $28.00 in a research report on Wednesday, August 19th. Mizuho set a $24.00 target price on Pediatrix Medical Group in a report on Friday, May 8th. Truist Financial raised their target price on Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Finally, UBS Group lifted their price target on Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a report on Thursday, August 6th. Seven research analysts have rated the stock with a Hold rating, According to MarketBeat, Pediatrix Medical Group presently has an average rating of “Hold” and a consensus target price of $25.00.

Pediatrix Medical Group Price Performance

Shares of MD stock opened at $26.81 on Friday. The firm has a market cap of $2.18 billion, a price-to-earnings ratio of 12.83 and a beta of 0.66. Pediatrix Medical Group, Inc. has a 12 month low of $15.69 and a 12 month high of $27.94. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.45. The stock has a 50-day moving average price of $26.00 and a 200 day moving average price of $23.15.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.04. The company had revenue of $487.78 million for the quarter, compared to the consensus estimate of $478.49 million. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. The company’s revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.53 EPS. Research analysts expect that Pediatrix Medical Group, Inc. will post 2.17 EPS for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.